CD30-POSITIVE NEOPLASTIC CELLS PRESENT

Clinical trials for CD30-POSITIVE NEOPLASTIC CELLS PRESENT explained in plain language.

Never miss a new study

Get alerted when new CD30-POSITIVE NEOPLASTIC CELLS PRESENT trials appear

Sign up with your email to follow new studies for CD30-POSITIVE NEOPLASTIC CELLS PRESENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat mesothelioma

Disease control Recruiting now

This study is testing whether the drug brentuximab vedotin can help control advanced malignant mesothelioma that has a specific marker called CD30 and cannot be removed by surgery. About 55 patients who have already tried other treatments will receive the drug through an IV every…

Matched conditions: CD30-POSITIVE NEOPLASTIC CELLS PRESENT

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

CD30-POSITIVE NEOPLASTIC CELLS PRESENT

Get alerted when new CD30-POSITIVE NEOPLASTIC CELLS PRESENT trials appear

New hope for Tough-to-Treat mesothelioma